COVID-19

COVID19 antibody study in Spain warns herd immunity cannot be achieved without devastating effects 2

Read full article here:

A study in Spain has found that only a small percentage of people have COVID-19 antibodies, warningthat herd immunity will be difficult to achieve. With at least 251,789 diagnosed cases and at least 23,388 deaths, Spain has been one of the worst-affected countries in the coronavirus pandemic, according to data from Johns Hopkins University. The Spanish study, which was published in the Lancet, involved more than 61,000 participants. Experts from the Institute of Health Carlos III in Madrid, the Spanish Ministry of Health and Harvards T. H. Chan School of Public Health worked on the project. SCOTLAND EDGES CLOSER TOWARDS TOTAL ELIMINATION OF CORONAVIRUSJust 5 percent of those surveyed had antibodies, a number which fell to less than 3 percent in coastal regions, although this was higher in some other parts of Spain. More than 10 percent of people surveyed around Madrid, for example, had antibodies. To achieve herd immunity, it is estimated that typically 70 to 90 percent of a population needs immunity, although this depends on how contagious the infection is. The study found that, despite the high impact of COVID-19 in Spain, estimates of the prevalence of antibodies remain low and are clearly insufficient to provide herd immunity. This cannot be achieved without accepting the collateral damage of many deaths in the susceptible population and overburdening of health systems, the researchers wrote. In this situation, social distance measures and efforts to identify and isolate new cases and their contacts are imperative for future epidemic control. FIRST VOLUNTEER RECEIVES EXPERIMENTAL COVID-19 VACCINE DEVELOPED BY IMPERIAL COLLEGE IN UK TRIALWhen combined with previous evidence, the research also found that approximately a third of people with SARS-CoV-2 infection remain asymptomatic. CLICK HERE TO GET THE FOX NEWS APPAs of Tuesday morning, more than 11. 6 million coronavirus cases have been diagnosed worldwide,